NB Renaissance and Ardian to Acquire Majority Stake in Neopharmed Gentili

NB Renaissance Acquires Arbo S.p.A.

April 25, 2022

Building Products

NB Renaissance, the Italian private equity arm of Neuberger Berman, has acquired a majority stake in Arbo S.p.A., an Italian distributor of heating-system spare parts, air-conditioning systems and plumbing products. The investment will support consolidation across Italy and accelerate Arbo's international growth; sellers included Bravo Capital and Narval Investimenti.

GHO Capital Leads Consortium to Acquire Majority Stake in Envision Pharma Group from Ardian

November 5, 2020

Healthcare Services

GHO Capital Partners, leading a consortium that includes Mubadala Investment Company, HarbourVest Partners and Northwestern Mutual, together with Envision management and employees, has acquired a majority stake in Envision Pharma Group as Ardian exits its investment. The transaction will support Envision's continued growth, wider rollout of its iEnvision medical affairs platform and strategic acquisitions to expand its medical affairs, communications and technology capabilities.

Essential Pharma Acquires Renaissance Pharma Ltd

April 2, 2024

Pharmaceuticals

Essential Pharma has completed the acquisition of all issued share capital of Renaissance Pharma Ltd, gaining the clinical-stage immunotherapy Hu14.18K322A (Hu14.18) for treatment of high‑risk neuroblastoma. The deal adds a development‑stage rare disease oncology asset to Essential Pharma's portfolio; Renaissance's CEO Simon Ball and members of the Renaissance team will continue to work with Essential on further development in partnership with St. Jude Children's Research Hospital.

ARCHIMED Acquires Majority Stake in Cardioline

November 17, 2021

Medical Devices

Trans-Atlantic private equity firm ARCHIMED has acquired a majority stake in Cardioline, a Trento, Italy-based maker of cardiology devices and Europe's largest provider of cardiology-focused telemedicine. The investment, made through ARCHIMED's MED III Fund, will support Cardioline's product and software development, international expansion and potential add-on M&A while founders retain a significant minority stake and remain in management.

Ardian Acquires Stake in Groupe Orion

June 11, 2024

Wealth Management

Ardian has acquired a stake in France-based wealth manager Groupe Orion alongside founders Manuel Parent and Emmanuel Angelier, with Siparex ETI selling its entire holding. The investment will support Groupe Orion’s growth and consolidation strategy, accelerate product and digital development (including its Canopia solution), and back further organic and external growth initiatives.

GHO Capital Acquires Ardena, a European Early‑Stage CDMO

January 9, 2020

Pharmaceuticals

GHO Capital Partners LLP has acquired Ardena, a Belgium‑headquartered contract development and manufacturing organisation (CDMO) focused on early‑phase drug development, from Mentha Capital and existing management. GHO will partner with Ardena's management to accelerate international growth, broaden the company’s service offering and build a fully integrated early‑stage CDMO platform through organic and inorganic expansion.